BETA

Activities of Giovanni LA VIA related to 2014/2207(INI)

Plenary speeches (1)

Safer healthcare in Europe (A8-0142/2015 - Piernicola Pedicini) IT
2016/11/22
Dossiers: 2014/2207(INI)

Amendments (6)

Amendment 47 #
Motion for a resolution
Recital M a (new)
Ma. whereas vaccination is an effective way to reduce the threat of antibacterial resistance by preventing infections that would need treatment with antibacterials and thereby reducing development of resistance;
2015/03/09
Committee: ENVI
Amendment 64 #
Motion for a resolution
Recital O
O. whereas resistance to antibiotics for certain bacteria is at least 25 % or more in several Member States; whereas antibiotic resistance is spreading much faster than the introduction of new antibiotics into clinical practice and that this is linked to scientific, regulatory and economic challenges;
2015/03/09
Committee: ENVI
Amendment 65 #
Motion for a resolution
Recital O a (new)
Oa. whereas antibacterial research and development presents some unique challenges meaning that a long term perspective is needed to develop the expertise and apply it in laboratories and whereas it is regrettable that many researchers with such an expertise have moved in other areas due to a lack of both private and public funding;
2015/03/09
Committee: ENVI
Amendment 77 #
Motion for a resolution
Recital Q
Q. whereas it is of paramount importance to encourage pharmaceutical companies to continue investing and to invest in developing new antibiotic compounds, in particular with activity against prevalent multidrug-resistant Gram-negative bacteria such as K. pneumoniae and Acinetobacterthose diseases for which antimicrobial resistance is a serious concern such as K. pneumonia, E. Coli, Acinetobacter, staphylococcus aureus, HIV, Tuberculosis and Malaria, by creating a new market model to incentivise investment in research and development and focus it on highest public health needs;
2015/03/09
Committee: ENVI
Amendment 97 #
Motion for a resolution
Recital S a (new)
Sa. whereas patients, families and patient organisations play a key role in advocating for safer care, and their role should be promoted through patient empowerment and participation in the healthcare process and policy at all levels;
2015/03/09
Committee: ENVI
Amendment 265 #
Motion for a resolution
Paragraph 22 – point f a (new)
fa) increase public funding and new academic positions to focus on exploring and validating new approaches for treating bacterial infections;
2015/03/09
Committee: ENVI